SCHEMBL17786108

SCHEMBL17786108

CS(=O)(=O)N1CCC(c2c(N)cccc2C(N)=O)CC1

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 3/20 0.44
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
SYK P43405 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
MAPT P10636 1/20 0.41
PARP2 Q9UGN5 1/20 0.41
JAK2 O60674 1/20 0.41
JAK3 P52333 1/20 0.41
LMNA P02545 2/20 0.39
RAB9A P51151 1/20 0.39
TP53 P04637 1/20 0.39
TSHR P16473 1/20 0.39
HTT P42858 1/20 0.39
ALDH1A1 P00352 3/20 0.39
CDK1 P06493 1/20 0.39
CDK4 P11802 1/20 0.39
CCND1 P24385 1/20 0.39
CDK2 P24941 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2465997 0.84 SYK (0.43) PARP1MEN1KMT2ASYKNPSR1
SCHEMBL17786110 0.82 PARP1 (0.44) PARP1MEN1KMT2ASYKNPSR1
SCHEMBL28020430 0.78 PARP1 (0.40) PARP1MEN1KMT2AMAPTTP53
SCHEMBL4560309 0.78 PARP1 (0.58) PARP1PARP2
SCHEMBL17786116 0.77 ALDH1A1 (0.44) PARP1MEN1KMT2ALMNATSHR
SCHEMBL7226255 0.77 PARP1 (0.43) PARP1MEN1KMT2AMAPTPARP2
Hydrochloric Acid SCHEMBL27632601 0.76 PARP1 (0.42) PARP1MEN1KMT2AMAPTPARP2
SCHEMBL26606681 0.76 HTT (0.39) MEN1KMT2ANPSR1MAPTLMNA
SCHEMBL28307571 0.73 IDO1 (0.42) MEN1KMT2ANPSR1MAPTLMNA
SCHEMBL17786120 0.72 CRBN (0.34) PARP1MAPTTSHRALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016086153-A2 USE OF TETRAHYDRO!NDAZOLYLBEIMZAMIDE AND TETRAHYDROINDOLYLBENZAMIDE DERIVATIVES FOR THE TREATMENT OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) AND ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS) ESANEX, INC. (US) 2016-06-02 WO disclosed